Expert Review of Anti-Infective Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.6 | Q1 | 82.3% | 1.024 | Q1 | 84.5% |
| 2024 | 3.8 | Q1 | 78.8% | 1.090 | Q1 | 86.3% |
| 2023 | 4.2 | Q1 | 79.4% | 1.260 | Q1 | 90.1% |
| 2022 | 5.7 | Q1 | 87.3% | 1.270 | Q1 | 90.8% |
| 2021 | 5.9 | Q1 | 84.7% | 1.078 | Q2 | 88.0% |
| 2020 | — | — | 1.211 | Q2 | 89.1% | |
| 2019 | — | — | 1.122 | Q2 | 88.0% | |
| 2018 | — | — | 1.145 | Q2 | 87.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1744-8336
ISSN
1478-7210
country
GBcoverage
2003-2026